Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer

scientific article published on June 2002

Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/SJ.BJC.6600336
P932PMC publication ID2375406
P698PubMed publication ID12087451
P5875ResearchGate publication ID11288873

P2093author name stringD Fuchs
B Widner
T G Allen-Mersh
A Huang
D C Henderson
C Glover
P2860cites workThe hospital anxiety and depression scaleQ27860968
Modulation of cellular tryptophan metabolism in human fibroblasts by transforming growth factor-beta: selective inhibition of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA synthetase gene expressionQ28281800
Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouseQ28317802
Increased neopterin concentrations in patients with cancer: indicator of oxidative stress?Q33724349
Cancer cachexia and depressive states: a neuro-endocrine-immunological disease?Q34065106
Clinical and physiological consequences of rapid tryptophan depletionQ34076826
Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom ChecklistQ35982281
Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cellsQ36350042
Sickness behaviour, an animal equivalent to human quality of life, is improved in septic rats by G-CSF and antibiotic prophylaxis.Q51356875
A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer.Q51991229
Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum.Q53510246
Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan.Q55054754
The Sickness Impact Profile: Development and Final Revision of a Health Status MeasureQ55063071
Immunoendocrine aspects of major depressionQ56767477
Brain mechanisms associated with depressive relapse and associated cognitive impairment following acute tryptophan depletionQ57004092
Simultaneous measurement of serum tryptophan and kynurenine by HPLCQ61906305
Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptomsQ61906369
Plasma and CSF tryptophan in cancer anorexiaQ68913203
Immune reaction links disease progression in cancer patients with depressionQ74029838
Relation between depression and circulating immune products in patients with advanced colorectal cancerQ77557667
Phase I study of percutaneous cryotherapy for colorectal liver metastasisQ77711464
Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolismQ37349845
Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphomaQ39024873
Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter.Q40386571
Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis.Q40595922
Brain tryptophan and the neoplastic anorexia-cachexia syndromeQ40608875
Transmembrane signaling by the interleukin-2 receptor: progress and conundrumsQ40790156
Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cells and cell lines by interferon-gamma.Q41993576
Measurement of response to treatment in colorectal liver metastasesQ42209034
Mania induced by risperidone: dose related?Q42544508
Fatigue in cancerQ42772667
Paroxetine for the prevention of depression induced by high-dose interferon alfaQ43556890
Contribution of diet, tumour volume and patient-related factors to weight loss in patients with colorectal liver metastasesQ47263654
Relation between tumor size, quality of life, and survival in patients with colorectal liver metastasesQ47341724
Weight loss in patients with hematological neoplasias is associated with immune system stimulationQ47400302
Fibrinogen synthesis is elevated in fasting cancer patients with an acute phase responseQ47752980
Cytokines and sickness behavior.Q47966462
Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6.Q48139231
Tryptophan depletion in normal volunteers produces selective impairment in memory consolidationQ48255846
Plasma tryptophan and anorexia in human cancerQ48409926
Relapse of depression after rapid depletion of tryptophanQ48758651
Differential pharmacology of newer antidepressants.Q48774817
Changes in brain amines associated with cancer anorexiaQ48849907
P275copyright licenseCreative Commons Attribution-NonCommercial-ShareAlike 3.0 UnportedQ15643954
P6216copyright statuscopyrightedQ50423863
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectcolorectal cancerQ188874
P304page(s)1691-1696
P577publication date2002-06-01
P1433published inBritish Journal of CancerQ326309
P1476titleSerum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer
P478volume86

Reverse relations

cites work (P2860)
Q41582112(-)-Epigallocatechin gallate inhibits the expression of indoleamine 2,3-dioxygenase in human colorectal cancer cells
Q34336333A novel serum metabolomics-based diagnostic approach for colorectal cancer
Q64249063AMPKα2 knockout enhances tumour inflammation through exacerbated liver injury and energy deprivation-associated AMPKα1 activation
Q33952214An observational cohort study of the kynurenine to tryptophan ratio in sepsis: association with impaired immune and microvascular function
Q33870256BAR the door: cancer suppression by amphiphysin-like genes
Q37874555Branched-chain amino acids as pharmacological nutrients in chronic liver disease
Q45902054Cancer and intercellular cooperation.
Q45959519Changes in serum tryptophan catabolism as an indicator of disease activity in adult T-cell leukemia/lymphoma.
Q37024095Characterization of the microbiome of nipple aspirate fluid of breast cancer survivors
Q47596077Clinical significance of tryptophan catabolism in Hodgkin lymphoma.
Q99560869Clinical significance of tryptophan catabolism in follicular lymphoma
Q50100354Conceptual Challenges in the Theoretical Foundations of Systems Biology.
Q53727618Construction of a highly sensitive signal-on aptasensor based on gold nanoparticles/functionalized silica nanoparticles for selective detection of tryptophan.
Q64964763Depression in terminally ill patients with cancer.
Q42172050Diminished quality of life in patients with cancer correlates with tryptophan degradation
Q38892525Early Immune Regulatory Changes in a Primary Controlled Human Plasmodium vivax Infection: CD1c+ Myeloid Dendritic Cell Maturation Arrest, Induction of the Kynurenine Pathway, and Regulatory T Cell Activation
Q36535642Effect of branched-chain amino acid-enriched nutritional supplementation on interferon therapy in Japanese patients with chronic hepatitis C virus infection: a retrospective study
Q54190983Expression of indoleamine 2,3-dioxygenase in leukemic cells indicates an unfavorable prognosis in acute myeloid leukemia patients with intermediate-risk cytogenetics.
Q34277561Fatigue in patients with lung cancer is related with accelerated tryptophan breakdown
Q34546698Formation of an N-formylkynurenine-derived fluorophore and its use for measuring indoleamine 2,3-dioxygenase 1 activity
Q37445053Functional metagenomic profiling of intestinal microbiome in extreme ageing
Q46951192HCV patients, psychopathology and tryptophan metabolism: analysis of the effects of pegylated interferon plus ribavirin treatment
Q35221827Helicobacter pylori and serum kynurenine-tryptophan ratio in patients with colorectal cancer
Q38047057Host indoleamine 2,3-dioxygenase: contribution to systemic acquired tumor tolerance.
Q41945018IL-32 induces indoleamine 2,3-dioxygenase+CD1c+ dendritic cells and indoleamine 2,3-dioxygenase+CD163+ macrophages: Relevance to mycosis fungoides progression
Q28180117Immune activation and degradation of tryptophan in coronary heart disease
Q34936678Immuno-regulatory function of indoleamine 2,3 dioxygenase through modulation of innate immune responses
Q37144901Immunosuppression routed via the kynurenine pathway: a biochemical and pathophysiologic approach.
Q96953606Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies
Q50223024Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism
Q34603340Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms
Q27025063Indoleamine 2,3 dioxygenase in intestinal disease
Q63366136Indoleamine 2,3-dioxygenase 1 inhibition targets anti-PD1-resistant lung tumors by blocking myeloid-derived suppressor cells
Q36809762Indoleamine 2,3-dioxygenase and tumor-induced tolerance
Q60921434Indoleamine 2,3-dioxygenase expression and overall survival in patients diagnosed with breast cancer in Pakistan
Q93045394Induction of tryptophan hydroxylase in the liver of s.c. tumor model of prostate cancer
Q90176765Inflammation-Induced Tryptophan Breakdown is Related With Anemia, Fatigue, and Depression in Cancer
Q38366476Inflammation-induced activation of the indoleamine 2,3-dioxygenase pathway: Relevance to cancer-related fatigue
Q34616168Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds.
Q48241209Kynurenine metabolism predicts cognitive function in patients following cardiac bypass and thoracic surgery
Q34633683Kynurenine pathway metabolites in humans: disease and healthy States
Q42498228Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients.
Q37522460Manipulation of indoleamine 2,3 dioxygenase; a novel therapeutic target for treatment of diseases
Q38859547Mechanisms of Inflammation-Associated Depression: Immune Influences on Tryptophan and Phenylalanine Metabolisms
Q34618252Metabolic signatures of extreme longevity in northern Italian centenarians reveal a complex remodeling of lipids, amino acids, and gut microbiota metabolism
Q53061043Metabolomics biomarkers of frailty in elderly breast cancer patients.
Q41050161Neopterin as a biomarker of immune response in cancer patients
Q61906267Non-invasive monitoring of kidney allograft rejection through IDO metabolism evaluation
Q55346219Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors.
Q36012223Picolinic acid in patients with chronic hepatitis C infection: a preliminary report
Q44763703Possible role of cytokine-induced tryptophan degradation in anaemia of inflammation
Q33818264Potential role of tryptophan and chloride in the inhibition of human myeloperoxidase
Q36052673Pre-treatment effects of peripheral tumors on brain and behavior: neuroinflammatory mechanisms in humans and rodents.
Q42216809Predictive and prognostic role of serum neopterin and tryptophan breakdown in prostate cancer
Q38718929Prevention and treatment of cancers by immune modulating nutrients.
Q37833087Prognostication of diffuse large B-cell lymphoma in the rituximab era.
Q36747510Relationship between indoleamine 2,3-dioxygenase activity and lymphatic invasion propensity of colorectal carcinoma
Q90706531Resistance Exercise Reduces Kynurenine Pathway Metabolites in Breast Cancer Patients Undergoing Radiotherapy
Q47163480Revisiting the tryptophan-serotonin deficiency and the inflammatory hypotheses of major depression in a biopsychosocial approach
Q30893057Selective paired ion contrast analysis: a novel algorithm for analyzing postprocessed LC-MS metabolomics data possessing high experimental noise
Q39659168Serum concentrations of l-kynurenine predict clinical outcomes of patients with peripheral T-cell lymphoma, not otherwise specified
Q45226436St. John's wort (Hypericum perforatum) counteracts cytokine-induced tryptophan catabolism in vitro
Q36476449Systemic delivery of Salmonella typhimurium transformed with IDO shRNA enhances intratumoral vector colonization and suppresses tumor growth
Q26775471Targeting the indoleamine 2,3-dioxygenase pathway in cancer
Q93134464The Plasma [Kynurenine]/[Tryptophan] Ratio and Indoleamine 2,3-Dioxygenase: Time for Appraisal
Q38974424The Potential Role of Cannabinoids in Modulating Serotonergic Signaling by Their Influence on Tryptophan Metabolism
Q91975772The Role of Tryptophan-Kynurenine in Feather Pecking in Domestic Chicken Lines
Q37959968The dendritic cell-regulatory T lymphocyte crosstalk contributes to tumor-induced tolerance
Q38356502The potential of targeting indoleamine 2,3-dioxygenase for cancer treatment.
Q41149149The status of immunosuppression in patients with stage IIIB or IV non-small-cell lung cancer correlates with the clinical characteristics and response to chemotherapy
Q36143029Translational approaches to treatment-induced symptoms in cancer patients.
Q33912950Tryptophan degradation in women with breast cancer: a pilot study
Q91559758Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
Q34942871Utility of kynurenic acid for non-invasive detection of metastatic spread to lymph nodes in non-small cell lung cancer
Q33600013Vitamin E status and quality of life in the elderly: influence of inflammatory processes

Search more.